Michael S. Kallos

3.7k total citations
91 papers, 2.8k citations indexed

About

Michael S. Kallos is a scholar working on Molecular Biology, Biomedical Engineering and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael S. Kallos has authored 91 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 42 papers in Biomedical Engineering and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael S. Kallos's work include Pluripotent Stem Cells Research (50 papers), 3D Printing in Biomedical Research (36 papers) and Mesenchymal stem cell research (15 papers). Michael S. Kallos is often cited by papers focused on Pluripotent Stem Cells Research (50 papers), 3D Printing in Biomedical Research (36 papers) and Mesenchymal stem cell research (15 papers). Michael S. Kallos collaborates with scholars based in Canada, United States and Switzerland. Michael S. Kallos's co-authors include Ian D. Gates, Leo A. Behie, Punitkumar R. Kapadia, Arindom Sen, Derrick E. Rancourt, Nicole I. zur Nieden, Roman Krawetz, Jeff Biernaskie, Jingyi Wang and Christopher Hunter and has published in prestigious journals such as Biomaterials, Scientific Reports and Brain Research.

In The Last Decade

Michael S. Kallos

91 papers receiving 2.7k citations

Peers

Michael S. Kallos
Zihao Liu China
Zhe Li China
Gang Wu China
Dan Lin China
Michael S. Kallos
Citations per year, relative to Michael S. Kallos Michael S. Kallos (= 1×) peers Leo A. Behie

Countries citing papers authored by Michael S. Kallos

Since Specialization
Citations

This map shows the geographic impact of Michael S. Kallos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Kallos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Kallos more than expected).

Fields of papers citing papers by Michael S. Kallos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Kallos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Kallos. The network helps show where Michael S. Kallos may publish in the future.

Co-authorship network of co-authors of Michael S. Kallos

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Kallos. A scholar is included among the top collaborators of Michael S. Kallos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Kallos. Michael S. Kallos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
John, Cini Mathew, et al.. (2024). High-titer manufacturing of SARS-CoV-2 Spike-pseudotyped VSV in stirred-tank bioreactors. Molecular Therapy — Methods & Clinical Development. 32(1). 101189–101189. 1 indexed citations
3.
Roberts, Eugene L., et al.. (2023). Computer controlled expansion of equine cord blood mesenchymal stromal cells on microcarriers in 3 L vertical-wheel® bioreactors. Frontiers in Bioengineering and Biotechnology. 11. 1250077–1250077. 1 indexed citations
4.
Kallos, Michael S., et al.. (2023). Suicide gene‐enabled cell therapy: A novel approach to scalable human pluripotent stem cell quality control. BioEssays. 45(11). e2300037–e2300037. 2 indexed citations
5.
Chu, Tak‐Ho, et al.. (2023). A Multi-Stage Bioprocess for the Expansion of Rodent Skin-Derived Schwann Cells in Computer-Controlled Bioreactors. International Journal of Molecular Sciences. 24(6). 5152–5152. 1 indexed citations
6.
Borys, Breanna S., Tiffany Dang, Leili Rohani, et al.. (2021). Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors. Stem Cell Research & Therapy. 12(1). 52 indexed citations
7.
Borys, Breanna S., Tiffany Dang, Tamás Révay, et al.. (2020). Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors. Stem Cells Translational Medicine. 9(9). 1036–1052. 38 indexed citations
8.
Rohani, Leili, Breanna S. Borys, Shiying Liu, et al.. (2020). Stirred suspension bioreactors maintain naïve pluripotency of human pluripotent stem cells. Communications Biology. 3(1). 492–492. 19 indexed citations
9.
Borys, Breanna S., et al.. (2020). Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products. Bioengineering. 7(2). 31–31. 16 indexed citations
10.
Mirfeizi, Leila, Jo Anne Stratton, Ranjan Kumar, et al.. (2017). Serum-free bioprocessing of adult human and rodent skin-derived Schwann cells: implications for cell therapy in nervous system injury. Journal of Tissue Engineering and Regenerative Medicine. 11(12). 3385–3397. 10 indexed citations
11.
Midha, Rajiv, et al.. (2016). Microcarrier Screening for Skin-derived Precursor Schwann Cell Culture in Stirred Tank Bioreactors. 39(1). 1 indexed citations
12.
Borys, Breanna S., et al.. (2016). Large‐scale expansion of human skin‐derived precursor cells (hSKPs) in stirred suspension bioreactors. Biotechnology and Bioengineering. 113(12). 2725–2738. 13 indexed citations
13.
Shakhbazau, Antos, Leila Mirfeizi, Holly Wobma, et al.. (2015). Inter‐microcarrier transfer and phenotypic stability of stem cell‐derived Schwann cells in stirred suspension bioreactor culture. Biotechnology and Bioengineering. 113(2). 393–402. 5 indexed citations
15.
Krawetz, Roman, et al.. (2011). Efficient suspension bioreactor expansion of murine embryonic stem cells on microcarriers in serum‐free medium. Biotechnology Progress. 27(3). 811–823. 36 indexed citations
16.
Krawetz, Roman, et al.. (2010). Serum‐free scaled up expansion and differentiation of murine embryonic stem cells to osteoblasts in suspension bioreactors. Biotechnology and Bioengineering. 106(5). 829–840. 13 indexed citations
17.
Taiani, Jaymi T., Roman Krawetz, Nicole I. zur Nieden, et al.. (2009). Reduced Differentiation Efficiency of Murine Embryonic Stem Cells in Stirred Suspension Bioreactors. Stem Cells and Development. 19(7). 989–998. 49 indexed citations
18.
Krawetz, Roman, Jaymi T. Taiani, Shiying Liu, et al.. (2009). Large-Scale Expansion of Pluripotent Human Embryonic Stem Cells in Stirred-Suspension Bioreactors. Tissue Engineering Part C Methods. 16(4). 573–582. 122 indexed citations
19.
Sen, Arindom, et al.. (2004). Cell cycle kinetics of expanding populations of neural stem and progenitor cells in vitro. Biotechnology and Bioengineering. 88(3). 332–347. 26 indexed citations
20.
Kallos, Michael S., Leo A. Behie, & Angelo L. Vescovi. (1999). Extended serial passaging of mammalian neural stem cells in suspension bioreactors. Biotechnology and Bioengineering. 65(5). 589–599. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026